Improving hearing by regenerating hair cells in the cochlea
Enhancing hair cell regeneration in the mature cochlea: Modulating Sox gene control of supporting cell identity
This study is looking at ways to help people with hearing loss by figuring out how to turn certain cells in the ear into new hair cells that help us hear better, using special techniques to change the genes that control these cells.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10893455 on NIH RePORTER |
What this research studies
This research investigates how to enhance the regeneration of hair cells in the cochlea, which are crucial for hearing. The team is exploring the role of specific genes that control the identity of supporting cells, which can potentially be reprogrammed into hair cells. By manipulating these genes, the researchers aim to increase the number of regenerated hair cells, offering a new approach to restore hearing in individuals with acquired deafness. The study involves advanced genetic techniques to understand how these cells can be transformed effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing acquired deafness or hearing loss, particularly those with damage to their cochlear hair cells.
Not a fit: Patients with congenital hearing loss or those whose hearing loss is not related to cochlear hair cell damage may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for restoring hearing in patients with acquired hearing loss.
How similar studies have performed: Other research has shown promising results in regenerating hair cells through genetic manipulation, indicating that this approach has potential for success.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Mcgovern, Melissa — University of Pittsburgh at Pittsburgh
- Study coordinator: Mcgovern, Melissa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.